BE878804A - Vaccin combine contre la maladie de newcastle et le chute de ponte provoquee par des virus adeno-like - Google Patents
Vaccin combine contre la maladie de newcastle et le chute de ponte provoquee par des virus adeno-like Download PDFInfo
- Publication number
- BE878804A BE878804A BE0/197163A BE197163A BE878804A BE 878804 A BE878804 A BE 878804A BE 0/197163 A BE0/197163 A BE 0/197163A BE 197163 A BE197163 A BE 197163A BE 878804 A BE878804 A BE 878804A
- Authority
- BE
- Belgium
- Prior art keywords
- emi
- virus
- adeno
- liquid containing
- newcastle disease
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims description 87
- 208000010359 Newcastle Disease Diseases 0.000 title claims description 14
- 229960005486 vaccine Drugs 0.000 title description 42
- 239000007788 liquid Substances 0.000 claims description 44
- 239000000725 suspension Substances 0.000 claims description 21
- 241000711404 Avian avulavirus 1 Species 0.000 claims description 20
- 235000013601 eggs Nutrition 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 241000272525 Anas platyrhynchos Species 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- 239000012071 phase Substances 0.000 claims description 11
- 241000287828 Gallus gallus Species 0.000 claims description 10
- 230000035931 haemagglutination Effects 0.000 claims description 10
- 208000015181 infectious disease Diseases 0.000 claims description 10
- 239000008346 aqueous phase Substances 0.000 claims description 9
- 239000000470 constituent Substances 0.000 claims description 9
- 210000004027 cell Anatomy 0.000 claims description 8
- 238000004113 cell culture Methods 0.000 claims description 7
- 210000002950 fibroblast Anatomy 0.000 claims description 7
- 210000001161 mammalian embryo Anatomy 0.000 claims description 7
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 6
- 230000033001 locomotion Effects 0.000 claims description 6
- 238000005096 rolling process Methods 0.000 claims description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 4
- 230000000120 cytopathologic effect Effects 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 230000002458 infectious effect Effects 0.000 claims description 4
- 229960000380 propiolactone Drugs 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 238000012423 maintenance Methods 0.000 claims description 3
- 239000002736 nonionic surfactant Substances 0.000 claims description 3
- 229940056360 penicillin g Drugs 0.000 claims description 3
- 229960005322 streptomycin Drugs 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 210000004381 amniotic fluid Anatomy 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 229960003255 natamycin Drugs 0.000 claims description 2
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 claims description 2
- 239000004311 natamycin Substances 0.000 claims description 2
- 235000010298 natamycin Nutrition 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 239000002356 single layer Substances 0.000 claims description 2
- 229940031551 inactivated vaccine Drugs 0.000 claims 6
- 239000002480 mineral oil Substances 0.000 claims 3
- 150000001298 alcohols Chemical class 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 239000001963 growth medium Substances 0.000 claims 2
- 230000000937 inactivator Effects 0.000 claims 2
- 239000002609 medium Substances 0.000 claims 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 2
- 239000008158 vegetable oil Substances 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000004264 monolayer culture Methods 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 235000013330 chicken meat Nutrition 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 244000144977 poultry Species 0.000 description 8
- 235000013594 poultry meat Nutrition 0.000 description 8
- 241000271566 Aves Species 0.000 description 5
- 230000002779 inactivation Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 210000005229 liver cell Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 238000002255 vaccination Methods 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 239000012984 antibiotic solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical class [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000238367 Mya arenaria Species 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000003067 hemagglutinative effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000007482 viral spreading Effects 0.000 description 1
- 210000000605 viral structure Anatomy 0.000 description 1
- 229960004854 viral vaccine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10111—Atadenovirus, e.g. ovine adenovirus D
- C12N2710/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7809364 | 1978-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE878804A true BE878804A (fr) | 1980-03-14 |
Family
ID=19831538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/197163A BE878804A (fr) | 1978-09-14 | 1979-09-14 | Vaccin combine contre la maladie de newcastle et le chute de ponte provoquee par des virus adeno-like |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPS5547625A (cg-RX-API-DMAC7.html) |
| BE (1) | BE878804A (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA794760B (cg-RX-API-DMAC7.html) |
-
1979
- 1979-09-07 ZA ZA00794760A patent/ZA794760B/xx unknown
- 1979-09-14 JP JP11869279A patent/JPS5547625A/ja active Granted
- 1979-09-14 BE BE0/197163A patent/BE878804A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA794760B (en) | 1980-08-27 |
| JPS5547625A (en) | 1980-04-04 |
| JPS6220964B2 (cg-RX-API-DMAC7.html) | 1987-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1232249B1 (fr) | Pneumovirus du canard et vaccins correspondants | |
| EP0073547B1 (en) | Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines and infectious-bronchitis virus strain | |
| Lambrechts et al. | Challenge experiments to evaluate cross‐protection induced at the trachea and kidney level by vaccine strains and Belgian nephropathogenic isolates of avian infectious bronchitis virus | |
| US4224412A (en) | Living virus culture vaccine against canine distemper and method of preparing same | |
| FR2602791A1 (fr) | Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu | |
| US4559229A (en) | Avian proventriculitis vaccine | |
| US4505892A (en) | Infectious bronchitis vaccine for poultry | |
| JP2000295986A (ja) | トリレオウイルスの新規抗原クラス | |
| LU81687A1 (fr) | Vaccin combine contre la maladie de newcastle et la chute de ponte provoquee par des virus adeno-like | |
| RU2378014C2 (ru) | Ассоциированная вакцина против парагриппа-3, инфекционного ринотрахеита и коронавирусной инфекции крупного рогатого скота эмульсионная инактивированная | |
| EP2550015B1 (fr) | Vaccin vivant pour maladies aviaires | |
| RU2443429C2 (ru) | Вакцина ассоциированная против ньюкаслской болезни птиц, инфекционного бронхита кур, синдрома снижения яйценоскости-76, инфекционной бурсальной болезни и реовирусного теносиновита птиц инактивированная эмульсионная | |
| LU82018A1 (fr) | Vaccins contre des maladies provoquees par des reovirus et procede de preparation de ces vaccins | |
| NL8005577A (nl) | Werkwijze voor het bereiden van een vaccin. | |
| BE878804A (fr) | Vaccin combine contre la maladie de newcastle et le chute de ponte provoquee par des virus adeno-like | |
| WO1980002505A1 (en) | Combined in activated vaccine,ready for administration and process for the preparation of such vaccine,active against egg production drop caused by adeno like viruses and against diseases caused by reo viruses | |
| CH382917A (fr) | Procédé pour la production d'un virus-vaccin contre la maladie des chiens | |
| RU2480238C1 (ru) | Вакцина ассоциированная против ньюкаслской болезни, реовирусного теносиновита и метапневмовирусной инфекции птиц инактивированная эмульсионная | |
| JPS6244528B2 (cg-RX-API-DMAC7.html) | ||
| US3629396A (en) | Avian encephalomyelitis vaccine | |
| JPH05501565A (ja) | ワクチン接合体の使用方法、ワクチン調整物および製造品 | |
| NL7812359A (nl) | Vaccins tegen door reo virus veroorzaakte ziektever- schijnselen en werkwijze voor het bereiden van deze vaccins. | |
| JPS62201573A (ja) | 家禽用インフルエンザワクチン | |
| WO2009013551A2 (en) | Process for preparing viral vaccine | |
| USRE34013E (en) | Infectious bronchitis vaccine for poultry |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: GIST-BROCADES N.V. Effective date: 19910930 |